ALCOX:EPA
NicOx SA
€ 0.32
arrow_downward
-1.08%(-0.0035) 1D
10-р сарын 2, 17:35:29 (GMT+2) · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€ 0.32
High
€ 0.33
Low
€ 0.32
Mkt. cap
33.11 сая
Avg. vol.
160.60 мян
Volume
280.19 мян
52-wk high
€ 0.57
52-wk low
€ 0.28
EPS
-€ 0.03
Shares outstanding
97.55 сая
No. of employees
10
Open
€ 0.32
High
€ 0.33
Low
€ 0.32
Mkt. cap
33.11 сая
Avg. vol.
160.60 мян
Volume
280.19 мян
52-wk high
€ 0.57
52-wk low
€ 0.28
EPS
-€ 0.03
Shares outstanding
97.55 сая
No. of employees
10
News stories
From web sources and news partners
MarketBeat
·
5 минутын өмнө
Simmons First National (NASDAQ:SFNC) Stock Price Crosses Above 200-Day Moving Average - Time to Sell?
Simply Wall Street
·
39 минутын өмнө
Will Product Recalls Change ICU Medical (ICUI) Stock Narrative
Cryptonews.net
·
48 минутын өмнө
XRP to $2? Analyzing How Nasdaq Listing Could Impact Token Price
Yahoo Finance
·
1 цагийн өмнө
BillionToOne (NasdaqGS:BLLN) Stock Fair Value Edges Higher As Analysts Weigh Tech And Reimbursement Risk
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, Франц
Sector-
Websitenicox.com